Thursday, October 22, 2026 Published by AdvancedCare USA Inc.

TheraNews
Subscribe

Archive summary

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

Summary of reporting by rutlandherald 1 min read Markdown

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

Originally reported by rutlandherald. Read more

Source: https://www.rutlandherald.com/news/business/livanova-receives-u-s-food-and-drug-administration-premarket-approval-for-aura6000-system-to-treat/article_8e89b049-38e4-56a6-bc2d-6746e6312e35.html

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.